Comparison of darbepoetin alfa dosed weekly (QW) vs. extended dosing schedule (EDS) in the treatment of anemia in patients receiving multicycle chemotherapy in a randomized, phase 2, open-label trial

BACKGROUND: Chemotherapy-induced anemia (CIA) is responsive to treatment with erythropoiesis-stimulating agents (ESAs) such as darbepoetin alfa. Administration of ESAs on a synchronous schedule with chemotherapy administration could benefit patients by reducing clinic visits and potentially enhancin...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartzberg, Lee, Burkes, Ronald, Mirtsching, Barry, Rearden, Timothy, Silberstein, Peter, Yee, Lorrin, Inamoto, Amy, Lillie, Tom
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988026/
https://www.ncbi.nlm.nih.gov/pubmed/20973982
http://dx.doi.org/10.1186/1471-2407-10-581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988026/
https://www.ncbi.nlm.nih.gov/pubmed/20973982
http://dx.doi.org/10.1186/1471-2407-10-581

Ejemplares similares